{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=IV+Corticosteroid&page=2", "query": { "intervention": "IV Corticosteroid", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=IV+Corticosteroid&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-25T19:51:59.046Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00418145", "title": "Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "megadose oral methylprednisolone", "type": "DRUG" }, { "name": "IV methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fred Lublin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 16, "start_date": "2003-09", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2017-05-18", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 10, "location_summary": "New Brunswick, New Jersey • Brooklyn, New York • Buffalo, New York + 3 more", "locations": [ { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Brooklyn", "state": "New York" }, { "city": "Buffalo", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00418145" }, { "nct_id": "NCT00361049", "title": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "graft versus host disease prophylaxis/therapy", "type": "BIOLOGICAL" }, { "name": "fluorescence in situ hybridization", "type": "GENETIC" }, { "name": "immunoenzyme technique", "type": "OTHER" }, { "name": "immunohistochemistry staining method", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "in vitro-treated bone marrow transplantation", "type": "PROCEDURE" }, { "name": "management of therapy complications", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "GENETIC", "OTHER", "PROCEDURE" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2004-09", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2010-11-05", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 8, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00361049" }, { "nct_id": "NCT03389555", "title": "Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Sepsis", "Septic Shock", "Metabolic Disturbance" ], "interventions": [ { "name": "vitamin C, vitamin B1, hydrocortisone", "type": "DRUG" }, { "name": "Normal saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 205, "start_date": "2018-02-09", "completion_date": "2020-02-28", "has_results": true, "last_update_posted_date": "2021-02-16", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 13, "location_summary": "Phoenix, Arizona • Boston, Massachusetts • Cambridge, Massachusetts + 6 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cambridge", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03389555" }, { "nct_id": "NCT01536535", "title": "Predicting Response to Standardized Pediatric Colitis Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Mesalazine", "type": "DRUG" }, { "name": "IV Corticosteroid", "type": "DRUG" }, { "name": "Oral Corticosteroids", "type": "DRUG" }, { "name": "Additional Therapies", "type": "OTHER" }, { "name": "Colectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Connecticut Children's Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Years to 17 Years" }, "enrollment_count": 431, "start_date": "2012-07-10", "completion_date": "2018-04-30", "has_results": true, "last_update_posted_date": "2019-09-20", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 26, "location_summary": "Los Angeles, California • San Francisco, California • Hartford, Connecticut + 22 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01536535" }, { "nct_id": "NCT04104438", "title": "Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asses Immunosuppression Modulation on Renal Recovery Post LT" ], "interventions": [ { "name": "Basiliximab 20 MG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fady M Kaldas, M.D., F.A.C.S.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "78 Years", "sex": "ALL", "summary": "18 Years to 78 Years" }, "enrollment_count": 71, "start_date": "2021-01-15", "completion_date": "2024-09-30", "has_results": true, "last_update_posted_date": "2025-12-16", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04104438" }, { "nct_id": "NCT00849745", "title": "Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Systemic Lupus Erythematosus", "Systemic Sclerosis" ], "interventions": [ { "name": "Nonmyeloablative allogeneic stem cell transplant", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 4, "start_date": "2003-01", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2016-06-23", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00849745" }, { "nct_id": "NCT05415137", "title": "Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Sarcoidosis" ], "interventions": [ { "name": "Efzofitimod 3 mg/kg", "type": "DRUG" }, { "name": "Efzofitimod 5 mg/kg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "aTyr Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 268, "start_date": "2022-09-15", "completion_date": "2025-07-14", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05415137" }, { "nct_id": "NCT05110976", "title": "A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AZD8630", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 170, "start_date": "2021-12-16", "completion_date": "2023-08-02", "has_results": false, "last_update_posted_date": "2023-08-30", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 18, "location_summary": "Tempe, Arizona • Bakersfield, California • Glendale, California + 11 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Homestead", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05110976" }, { "nct_id": "NCT04632940", "title": "Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Duchenne Muscular Dystrophy" ], "interventions": [ { "name": "Pamrevlumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kyntra Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "MALE", "summary": "6 Years to 11 Years · Male only" }, "enrollment_count": 73, "start_date": "2021-03-03", "completion_date": "2023-12-14", "has_results": true, "last_update_posted_date": "2024-08-26", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 27, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Sacramento, California + 24 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04632940" }, { "nct_id": "NCT00350545", "title": "A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Graft vs Host Disease" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Cyclosporine A", "type": "DRUG" }, { "name": "tacrolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "75 Years", "sex": "ALL", "summary": "1 Year to 75 Years" }, "enrollment_count": 37, "start_date": "2006-08", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2017-11-20", "last_synced_at": "2026-09-25T19:51:59.046Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00350545" } ] }